Liu P,Hu Y,Liu C,et al. Effects of salviainolic acid A (SA-A) on liver injury: SA-A action on hepatic peroxidation [J]. Liver, 2001, 21(6): 384.
[2]
Wu Z M,Wen T,Tan Y F,et al. Effects of salvianolic acid a on oxidative stress and liver injury induced by carbon tetrachloride in rats[J]. Basic Clin Pharmacol Toxicol, 2007, 100(2): 115.
[3]
Lin Y L,Lee T F,Huang Y J,et al. Antiproliferative effect of salvianolic acid A on rat hepatic stellate cells[J]. J Pharm Pharmacol, 2006, 58(7): 933.
[4]
Liu C H,Liu P,Hu Y Y,et al. Effects of salvianolic acid-A on rat hepatic stellate cell proliferation and collagen production in culture[J]. Acta Pharmacol Sin, 2000, 21(8): 721.
[5]
Xu X,Hu Y,Zhai X,et al. Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice[J]. Toxicol Appl Pharmacol, 2013, 273(1): 68.
[6]
Yan X,Zhou T,Tao Y,et al. Salvianolic acid B attenuates hepatocyte apoptosis by regulating mediators in death receptor and mitochondrial pathways[J]. Exp Biol Med (Maywood), 2010, 235(5): 623.
[7]
Wang R,Yu X Y,Guo Z Y,et al. Inhibitory effects of salvianolic acid B on CCl(4)-induced hepatic fibrosis through regulating NF-kappaB/IkappaBalpha signaling[J]. J Ethnopharmacol, 2012, 144(3): 592.
Xu H,Zhou Y,Lu C,et al. Salvianolic acid B lowers portal pressure in cirrhotic rats and attenuates contraction of rat hepatic stellate cells by inhibiting RhoA signaling pathway[J]. Lab Invest, 2012, 92(12): 1738.
[10]
Lv Z,Song Y,Xue D,et al. Effect of salvianolic-acid B on inhibiting MAPK signaling induced by transforming growth factor-β1 in activated rat hepatic stellate cells[J]. J Ethnopharmacol, 2010, 132(2): 384.
Lin Y L,Wu C H,Luo M H,et al. In vitro protective effects of salvianolic acid B on primary hepatocytes and hepatic stellate cells[J]. J Ethnopharmacol, 2006, 105(1/2): 215.
[13]
Li S,Wang L,Yan X,et al. Salvianolic acid B attenuates rat hepatic fibrosis via downregulating angiotensin Ⅱ signaling[J]. Evid Based Complement Alternat Med, 2012, doi: 160726.
Tao Y Y,Wang Q L,Shen L,et al. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro[J]. Exp Biol Med (Maywood), 2013, 238(11): 1284.
Li M,Lu Y,Hu Y,et al. Salvianolic acid B protects against acute ethanol-induced liver injury through SIRT1-mediated deacetylation of p53 in rats[J]. Toxicol Lett, 2014, 228(2): 67.
[18]
Liu P,Hu Y Y,Liu C,et al. Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B[J]. World J Gastroenterol, 2002, 8(4): 679.
Zhao X,Jia H,Yang S,et al. Salvianolic acid B reducing portal hypertension depends on macrophages in isolated portal perfused rat livers with chronic hepatitis[J]. Evid Based Complement Alternat Med, 2012, doi:786365.
[21]
Kong R,Gao Y,Sun B,et al. The strategy of combined ischemia preconditioning and salvianolic acid-B pretreatment to prevent hepatic ischemia-reperfusion injury in rats[J]. Dig Dis Sci, 2009, 54(12): 2568.
[22]
Negi A S,Kumar J K,Luqman S,et al. Recent advances in plant hepatoprotectives: a chemical and biological profile of some important leads[J]. Med Res Rev, 2008, 28(5): 746.
[23]
Liu J. Pharmacology of oleanolic acid and ursolic acid[J]. J Ethnopharmacol, 1995, 49(2): 57.
[24]
Chen X,Guo J,Bao J,et al. The anticancer properties of Salvia miltiorrhiza bunge (danshen): a systematic review[J]. Med Res Rev, 2014, 34(4): 768.
[25]
Wang X,Morris-Natschke S L,Lee K H. New developments in the chemistry and biology of the bioactive constituents of Tanshen[J]. Med Res Rev, 2007, 27(1): 133.
[26]
Hu X,Rui W,Wu C,et al. Compound Astragalus and Salvia miltiorrhiza extracts suppress hepatocarcinogenesis by modulating transforming growth factor-β/Smad signaling[J]. J Gastroenterol Hepatol, 2014, 29(6): 1284.
[27]
Rui W,Xie L,Liu X,et al. Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription[J]. J Ethnopharmacol, 2014, 151(1): 198.
[28]
Hu S,Chen S M,Li X K,et al. Antitumor effects of chi-shen extract from Salvia miltiorrhiza and Paeoniae Radix on human hepatocellular carcinoma cells[J]. Acta Pharm Sin, 2007, 28(8): 1215.
[29]
Liu J,Yang C F,Wasser S,et al. Protection of Salvia miltiorrhiza against aflatoxin-B1-induced hepatocarcinogenesis in Fischer 344 rats dual mechanisms involved[J]. Life Sci, 2001, 69(3): 309.
[30]
Sferra R,Vetuschi A,Catitti V,et al. Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulation[J]. Eur Rev Med Pharmacol Sci, 2012, 16(11): 1484.
[31]
Yang Y,Yang S,Chen M,et al. Compound Astragalus and Salvia miltiorrhiza extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts[J]. J Ethnopharmacol, 2008, 118(2): 264.
[32]
Liu X,Yang Y,Zhang X,et al. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell[J]. J Gastroenterol Hepatol, 2010, 25(2): 420.
[33]
Ji W, Gong B Q. Hypolipidemic activity and mechanism of purified herbal extract of Salvia miltiorrhiza in hyperlipidemic rats[J]. J Ethnopharmacol, 2008, 119(2): 291.
[34]
Li C M,Dong X L,Fan X D,et al. Aqueous extract of danshen (Salvia miltiorrhiza Bunge) protects ovariectomized rats fed with high-fat diet from endothelial dysfunction[J]. Menopause, 2013, 20(1): 100.
[35]
Lee T Y,Chang H H,Wang G J,et al. Water-soluble extract of Salvia miltiorrhiza ameliorates carbon tetrachloride-mediated hepatic apoptosis in rats[J]. J Pharm Pharmacol, 2006, 58(5): 659.
[36]
Nan J X,Park E J,Kang H C,et al. Anti-fibrotic effects of a hot-water extract from Salvia miltiorrhiza roots on liver fibrosis induced by biliary obstruction in rats[J]. J Pharm Pharmacol, 2001, 53(2): 197.
[37]
Lima C F,Valentao P C,Andrade P B,et al. Water and methanolic extracts of Salvia officinalis protect HepG2 cells from t-BHP induced oxidative damage[J]. Chem Biol Interact, 2007, 167(2): 107.
[38]
Lee W Y,Cheung C C,Liu K W,et al. Cytotoxic effects of tanshinones from Salvia miltiorrhiza on doxorubicin-resistant human liver cancer cells[J]. J Nat Prod, 2010, 73(5): 854.
Che X H,Park E J,Zhao Y Z,et al. Tanshinone Ⅱ A induces apoptosis and S phase cell cycle arrest in activated rat hepatic stellate cells[J]. Basic Clin Pharmacol Toxicol, 2010, 106(1): 30.
[42]
Zhu B,Zhai Q,Yu B. Tanshinone ⅡA protects rat primary hepatocytes against carbon tetrachloride toxicity via inhibiting mitochondria permeability transition[J]. Pharm Biol, 2010, 48(5): 484.
[43]
Yin H Q,Kim Y S,Choi Y J,et al. Effects of tanshinone ⅡA on the hepatotoxicity and gene expression involved in alcoholic liver disease[J]. Arch Pharm Res, 2008, 31(5): 659.
[44]
Jin Q,Jiang S,Wu Y L,et al. Hepatoprotective effect of cryptotanshinone from Salvia miltiorrhiza in D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure[J]. Phytomedicine, 2014, 21(2): 141.
[45]
Yin H Q,Choi Y J,Kim Y C,et al. Salvia miltiorrhiza Bunge and its active component cryptotanshinone protects primary cultured rat hepatocytes from acute ethanol-induced cytotoxicity and fatty infiltration[J]. Food Chem Toxicol, 2009, 47(1): 98.
[46]
Park E J,Zhao Y Z,Kim Y C,et al. PF2401-SF, standardized fraction of Salvia miltiorrhiza and its constituents, tanshinone I, tanshinone ⅡA, and cryptotanshinone, protect primary cultured rat hepatocytes from bile acid-induced apoptosis by inhibiting JNK phosphorylation[J]. Food Chem Toxicol, 2007, 45(10): 1891.
[47]
Park E J, Zhao Y Z, Kim Y C, et al. Preventive effects of a purified extract isolated from Salvia miltiorrhiza enriched with tanshinone I, tanshinone ⅡA and cryptotanshinone on hepatocyte injury in vitro and in vivo[J]. Food Chem Toxicol, 2009, 47(11): 2742.
[48]
Wang X J,Wang Z B,Xu J X. Effect of salvianic acid A on lipid peroxidation and membrane permeability in mitochondria[J]. J Ethnopharmacol, 2005, 97(3): 441.
Wang C Y,Ma F L,Liu J T,et al. Protective effect of salvianic acid A on acute liver injury induced by carbon tetrachloride in rats[J]. Biol Pharm Bull, 2007, 30(1): 44.
Guo J,Zhang Y,Zeng L,et al. Salvianic acid A protects L-02 cells against γ-irradiation-induced apoptosis via the scavenging of reactive oxygen species[J]. Environ Toxicol Pharmacol, 2013, 35(1): 117.
[59]
Cao W,Guo X W,Zheng H Z,et al. Current progress of research on pharmacologic actions of salvianolic acid B[J]. Chin J Integr Med, 2012, 18(4): 316.
[60]
Tsai M K,Lin Y L,Huang Y T. Differential inhibitory effects of salvianolic acids on activation of rat hepatic stellate cells by platelet-derived growth factor[J]. Planta Med, 2011, 77(13): 1495.
[61]
Tsai M K, Lin Y L, Huang Y T. Effects of salvianolic acids on oxidative stress and hepatic fibrosis in rats[J]. Toxicol Appl Pharmacol, 2010, 242(2): 155.
